Sopris Capital Acquires Blackford Analysis from Bayer

Oct 12, 2026
Sopris Capital completed its acquisition of medical imaging AI company Blackford Analysis from Bayer and plans to combine it with Azra AI.

Sopris Capital completed its acquisition of Blackford Analysis from Bayer, the investment firm said in a press release. Financial terms were not disclosed.

Sopris Capital plans to combine Blackford with portfolio company Azra AI. Blackford will remain a separate legal entity, retain operations in Scotland and the United States, and continue serving existing hospital and original equipment manufacturer customers.

Blackford provides software that lets radiology departments evaluate, deploy, and manage medical imaging AI applications. Its platform includes more than 130 applications from over 45 vendors. Azra AI provides software for identifying and managing patients with cancer and other complex illnesses.

We hope you enjoyed this article

Free newsletter

AI Funding Brief

AI Token Webinar

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.